Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/ALPHAMAB-ONCOLOGY-103501724/actualite/Alphamab-Oncology-a-presente-a-l-Aacr-les-resultats-de-l-escalade-de-dose-du-JSKN003-chez-des-pa-46402680/?utm_source=whatsapp&utm_medium=social&utm_campaign=share